title: A systematic review update of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists.
authors.affiliation: Nuffield Institute for Health, University of Leeds, UK.
authors.forename: M
authors.initials: M
authors.lastname: Robinson
authors.forename: L
authors.initials: L
authors.lastname: Ginnelly
authors.forename: M
authors.initials: M
authors.lastname: Sculpher
authors.forename: L
authors.initials: L
authors.lastname: Jones
authors.lastname: Riemsma
authors.forename: S
authors.initials: S
authors.lastname: Palmer
authors.forename: Z
authors.initials: Z
authors.lastname: Philips
authors.forename: J
authors.initials: J
authors.lastname: Glanville
mesh_terms: D003327:Coronary Disease / Q000188:drug therapy* / Q000191:economics*; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000191:economics* / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D015912:Thrombolytic Therapy; D016896:Treatment Outcome; D006113:United Kingdom
chemical_list: D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex